The Scientist

» drug development, evolution, ecology and immunology

Most Recent

The state’s board of education approves new standards that ease up on having students dig into scientific issues relevant to “intelligent design” arguments.

0 Comments

image: Migratory Eels Use Magnetoreception

Migratory Eels Use Magnetoreception

By | April 14, 2017

In laboratory experiments that simulated oceanic conditions, the fish responded to magnetic fields, a sensory input that may aid migration.

0 Comments

image: Drugs OKed Faster in U.S. Than in Europe

Drugs OKed Faster in U.S. Than in Europe

By | April 10, 2017

In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: New Giant Virus Group Reported

New Giant Virus Group Reported

By | April 6, 2017

A genomic analysis of “Klosneuviruses” suggests that they evolved from small viruses that accumulated genetic material over time, but not all virologists are convinced. 

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

image: Infographic: Antibody Cancer Therapy

Infographic: Antibody Cancer Therapy

By | April 1, 2017

An experimental technique removes T cells that aid in vitro tumor growth.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS